Ws Management Lllp Ultragenyx Pharmaceutical Inc. Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$106.9 - $167.73 $86,268 - $135,358	-807 Reduced 4.83%	15,885 $1.81 Million
Q2 2020 Aug 13, 2020	SELL	$46.91 - $78.22 $134,913 - $224,960	-2,876 Reduced 14.7%	16,692 $1.31 Million
Q1 2020 May 13, 2020	SELL	$33.8 - $62.9 $33,293 - $61,956	-985 Reduced 4.79%	19,568 $869,000
Q3 2019 Nov 13, 2019	SELL	$42.5 - $63.11 $96,517 - $143,322	-2,271 Reduced 9.95%	20,553 $879,000
Q2 2019 Aug 13, 2019	SELL	$54.93 - $74.36 $148,530 - $201,069	-2,704 Reduced 10.59%	22,824 $1.45 Million
Q1 2019 May 13, 2019	SELL	$39.87 - $69.36 $137,312 - $238,875	-3,444 Reduced 11.89%	25,528 $1.77 Million
Q4 2018 Feb 12, 2019	SELL	$38.89 - $77.3 $977,227 - $1.94 Million	-25,128 Reduced 46.45%	28,972 $1.26 Million
Q2 2018 Aug 13, 2018	BUY	$48.54 - $85.31 $2.63 Million - $4.62 Million	54,100 New	54,100 $4.16 Million

329

85.9M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.18B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.